Literature DB >> 17984207

Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Lisa A Lewis1, Sanjay Ram, Alpana Prasad, Sunita Gulati, Silke Getzlaff, Anna M Blom, Ulrich Vogel, Peter A Rice.   

Abstract

Complement is a key arm of the innate immune defenses against the pathogenic neisseriae. We previously identified lipooligosaccharide on Neisseria meningitidis as an acceptor for complement C4b. Little is known about other neisserial targets for complement proteins C3 and C4, which covalently attach to bacterial surfaces and initiate opsonization and killing. In this study we demonstrate that Neisseria gonorrhoeae porin (Por) 1B selectively binds C4b via amide linkages and C3b via ester linkages. Using strains expressing hybrid Por1A/1B molecules, a region spanned by loops 4 and 5 of Por1B was identified as the preferred binding site for C4b. We also identified the opacity protein (Opa), a major adhesin of pathogenic neisseriae, as a target for C4b and C3b on both N. meningitidis and N. gonorrhoeae. Using N. gonorrhoeae variants that predominantly expressed individual Opa proteins, we found that all Opa proteins tested (A, B, C, D, E, F, and I) bound C4b and C3b via amide and ester linkages, respectively. Amide linkages with Por1B and Opa were confirmed using serum containing only the C4A isoform, which exclusively forms amide linkages with targets. While monomers and heterodimers of C4Ab were detected on bacterial targets, C4Bb appeared to preferentially participate in heterodimer (C5 convertase) formation. Our data provide another explanation for the enhanced serum sensitivity of Por1B-bearing gonococci. The binding of C3b and C4b to Opa provides a rationale for the recovery of predominantly "transparent" (Opa-negative) neisserial isolates from persons with invasive disease, where the bacteria encounter high levels of complement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984207      PMCID: PMC2223645          DOI: 10.1128/IAI.00613-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

Authors:  S Ram; F G Mackinnon; S Gulati; D P McQuillen; U Vogel; M Frosch; C Elkins; H K Guttormsen; L M Wetzler; M Oppermann; M K Pangburn; P A Rice
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

3.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 4.  Bacterial complement evasion.

Authors:  Suzan H M Rooijakkers; Jos A G van Strijp
Journal:  Mol Immunol       Date:  2006-07-27       Impact factor: 4.407

Review 5.  Gonococcal arthritis (disseminated gonococcal infection).

Authors:  Peter A Rice
Journal:  Infect Dis Clin North Am       Date:  2005-12       Impact factor: 5.982

6.  Organizations and gene duplications of the human and mouse MHC complement gene clusters.

Authors:  Z Yang; C Y Yu
Journal:  Exp Clin Immunogenet       Date:  2000

Review 7.  Molecular aberrations in human systemic lupus erythematosus.

Authors:  G C Tsokos; G M Kammer
Journal:  Mol Med Today       Date:  2000-11

8.  C4B deficiency: a risk factor for bacteremia with encapsulated organisms.

Authors:  N A Bishof; T R Welch; L S Beischel
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

9.  Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease.

Authors:  C A Blanchong; B Zhou; K L Rupert; E K Chung; K N Jones; J F Sotos; W B Zipf; R M Rennebohm; C Yung Yu
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

10.  Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.

Authors:  S Ram; M Cullinane; A M Blom; S Gulati; D P McQuillen; B G Monks; C O'Connell; R Boden; C Elkins; M K Pangburn; B Dahlbäck; P A Rice
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  28 in total

Review 1.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

2.  The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.

Authors:  Lisa A Lewis; Matthew Carter; Sanjay Ram
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

3.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

4.  Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Authors:  Morris D Cooper; Melissa H Roberts; Ona L Barauskas; Gary A Jarvis
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

5.  A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.

Authors:  Sanjay Ram; Sunita Gulati; Lisa A Lewis; Srinjoy Chakraborti; Bo Zheng; Rosane B DeOliveira; George W Reed; Andrew D Cox; Jianjun Li; Frank St Michael; Jacek Stupak; Xiao-Hong Su; Sudeshna Saha; Corinna S Landig; Ajit Varki; Peter A Rice
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

6.  Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.

Authors:  Sunita Gulati; Sarika Agarwal; Shreekant Vasudhev; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

7.  Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Bo Zheng; Caleb Carr; Isaac Bass; Sunita Gulati; Rosane B DeOliveira; Severin Gose; George W Reed; Marina Botto; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2018-09-28       Impact factor: 5.422

8.  Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.

Authors:  Lisa A Lewis; William M Shafer; Tathagat Dutta Ray; Sanjay Ram; Peter A Rice
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

9.  Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.

Authors:  Dan M Granoff; Jo Anne Welsch; Sanjay Ram
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 10.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.